nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Mitomycin—urinary bladder cancer	0.356	0.569	CiPCiCtD
Trabectedin—Alkylating Activity—Thiotepa—urinary bladder cancer	0.27	0.431	CiPCiCtD
Trabectedin—SRC—urinary bladder cancer	0.232	1	CbGaD
Trabectedin—PTGS1—Etoposide—urinary bladder cancer	0.0109	0.24	CbGbCtD
Trabectedin—CYP3A4—Thiotepa—urinary bladder cancer	0.00939	0.207	CbGbCtD
Trabectedin—CYP2E1—Etoposide—urinary bladder cancer	0.0084	0.185	CbGbCtD
Trabectedin—CYP2C9—Fluorouracil—urinary bladder cancer	0.00525	0.116	CbGbCtD
Trabectedin—CYP2C9—Cisplatin—urinary bladder cancer	0.00446	0.0982	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—urinary bladder cancer	0.00273	0.0602	CbGbCtD
Trabectedin—CYP3A4—Etoposide—urinary bladder cancer	0.00255	0.0561	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00174	0.0383	CbGbCtD
Trabectedin—CYP2C19—urine—urinary bladder cancer	0.00125	0.104	CbGeAlD
Trabectedin—CYP2C9—urine—urinary bladder cancer	0.000972	0.0809	CbGeAlD
Trabectedin—CYP2E1—urine—urinary bladder cancer	0.000921	0.0766	CbGeAlD
Trabectedin—SRC—prostate gland—urinary bladder cancer	0.000854	0.071	CbGeAlD
Trabectedin—CYP3A4—urine—urinary bladder cancer	0.000741	0.0617	CbGeAlD
Trabectedin—CYP2D6—urine—urinary bladder cancer	0.00073	0.0607	CbGeAlD
Trabectedin—SRC—epithelium—urinary bladder cancer	0.000627	0.0522	CbGeAlD
Trabectedin—SRC—smooth muscle tissue—urinary bladder cancer	0.000605	0.0503	CbGeAlD
Trabectedin—SRC—renal system—urinary bladder cancer	0.000582	0.0484	CbGeAlD
Trabectedin—SRC—female reproductive system—urinary bladder cancer	0.000466	0.0388	CbGeAlD
Trabectedin—CYP2E1—prostate gland—urinary bladder cancer	0.000331	0.0275	CbGeAlD
Trabectedin—PTGS1—prostate gland—urinary bladder cancer	0.000319	0.0265	CbGeAlD
Trabectedin—CYP2E1—seminal vesicle—urinary bladder cancer	0.00028	0.0233	CbGeAlD
Trabectedin—SRC—lymph node—urinary bladder cancer	0.000273	0.0227	CbGeAlD
Trabectedin—PTGS1—seminal vesicle—urinary bladder cancer	0.00027	0.0224	CbGeAlD
Trabectedin—PTGS1—epithelium—urinary bladder cancer	0.000234	0.0195	CbGeAlD
Trabectedin—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000226	0.0188	CbGeAlD
Trabectedin—CYP2E1—renal system—urinary bladder cancer	0.000225	0.0188	CbGeAlD
Trabectedin—CYP2C19—vagina—urinary bladder cancer	0.000222	0.0185	CbGeAlD
Trabectedin—CYP2E1—urethra—urinary bladder cancer	0.000221	0.0184	CbGeAlD
Trabectedin—PTGS1—renal system—urinary bladder cancer	0.000217	0.0181	CbGeAlD
Trabectedin—CYP2C9—female reproductive system—urinary bladder cancer	0.000191	0.0158	CbGeAlD
Trabectedin—CYP3A4—renal system—urinary bladder cancer	0.000181	0.0151	CbGeAlD
Trabectedin—CYP2E1—female reproductive system—urinary bladder cancer	0.000181	0.015	CbGeAlD
Trabectedin—CYP2D6—renal system—urinary bladder cancer	0.000179	0.0148	CbGeAlD
Trabectedin—PTGS1—female reproductive system—urinary bladder cancer	0.000174	0.0145	CbGeAlD
Trabectedin—PTGS1—vagina—urinary bladder cancer	0.000157	0.0131	CbGeAlD
Trabectedin—CYP3A4—female reproductive system—urinary bladder cancer	0.000145	0.0121	CbGeAlD
Trabectedin—CYP2D6—female reproductive system—urinary bladder cancer	0.000143	0.0119	CbGeAlD
Trabectedin—PTGS1—lymph node—urinary bladder cancer	0.000102	0.00846	CbGeAlD
Trabectedin—Dyspnoea—Gemcitabine—urinary bladder cancer	6.2e-05	0.00114	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—urinary bladder cancer	6.18e-05	0.00114	CcSEcCtD
Trabectedin—Insomnia—Fluorouracil—urinary bladder cancer	6.18e-05	0.00114	CcSEcCtD
Trabectedin—Anorexia—Cisplatin—urinary bladder cancer	6.17e-05	0.00114	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—urinary bladder cancer	6.16e-05	0.00114	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	6.15e-05	0.00113	CcSEcCtD
Trabectedin—Paraesthesia—Fluorouracil—urinary bladder cancer	6.13e-05	0.00113	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	6.09e-05	0.00112	CcSEcCtD
Trabectedin—Dyspnoea—Fluorouracil—urinary bladder cancer	6.09e-05	0.00112	CcSEcCtD
Trabectedin—Hypersensitivity—Thiotepa—urinary bladder cancer	6.09e-05	0.00112	CcSEcCtD
Trabectedin—Hypotension—Cisplatin—urinary bladder cancer	6.05e-05	0.00112	CcSEcCtD
Trabectedin—Decreased appetite—Gemcitabine—urinary bladder cancer	6.04e-05	0.00111	CcSEcCtD
Trabectedin—Dyspepsia—Fluorouracil—urinary bladder cancer	6.01e-05	0.00111	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	6e-05	0.00111	CcSEcCtD
Trabectedin—Fatigue—Gemcitabine—urinary bladder cancer	5.99e-05	0.00111	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	5.97e-05	0.0011	CcSEcCtD
Trabectedin—Constipation—Gemcitabine—urinary bladder cancer	5.94e-05	0.0011	CcSEcCtD
Trabectedin—Decreased appetite—Fluorouracil—urinary bladder cancer	5.94e-05	0.0011	CcSEcCtD
Trabectedin—Pancytopenia—Methotrexate—urinary bladder cancer	5.94e-05	0.0011	CcSEcCtD
Trabectedin—Asthenia—Thiotepa—urinary bladder cancer	5.93e-05	0.00109	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	5.9e-05	0.00109	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	5.9e-05	0.00109	CcSEcCtD
Trabectedin—Infection—Etoposide—urinary bladder cancer	5.89e-05	0.00109	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—urinary bladder cancer	5.87e-05	0.00108	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—urinary bladder cancer	5.84e-05	0.00108	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—urinary bladder cancer	5.82e-05	0.00107	CcSEcCtD
Trabectedin—Paraesthesia—Cisplatin—urinary bladder cancer	5.82e-05	0.00107	CcSEcCtD
Trabectedin—Thrombocytopenia—Etoposide—urinary bladder cancer	5.81e-05	0.00107	CcSEcCtD
Trabectedin—Dyspnoea—Cisplatin—urinary bladder cancer	5.77e-05	0.00107	CcSEcCtD
Trabectedin—Skin disorder—Etoposide—urinary bladder cancer	5.76e-05	0.00106	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	5.72e-05	0.00106	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—urinary bladder cancer	5.7e-05	0.00105	CcSEcCtD
Trabectedin—Anorexia—Etoposide—urinary bladder cancer	5.66e-05	0.00104	CcSEcCtD
Trabectedin—Diarrhoea—Thiotepa—urinary bladder cancer	5.65e-05	0.00104	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	5.64e-05	0.00104	CcSEcCtD
Trabectedin—Decreased appetite—Cisplatin—urinary bladder cancer	5.63e-05	0.00104	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	5.59e-05	0.00103	CcSEcCtD
Trabectedin—Infestation—Methotrexate—urinary bladder cancer	5.57e-05	0.00103	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—urinary bladder cancer	5.57e-05	0.00103	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—urinary bladder cancer	5.55e-05	0.00102	CcSEcCtD
Trabectedin—Hypotension—Etoposide—urinary bladder cancer	5.54e-05	0.00102	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	5.52e-05	0.00102	CcSEcCtD
Trabectedin—Body temperature increased—Gemcitabine—urinary bladder cancer	5.49e-05	0.00101	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—urinary bladder cancer	5.47e-05	0.00101	CcSEcCtD
Trabectedin—Dizziness—Thiotepa—urinary bladder cancer	5.46e-05	0.00101	CcSEcCtD
Trabectedin—Stomatitis—Methotrexate—urinary bladder cancer	5.43e-05	0.001	CcSEcCtD
Trabectedin—Body temperature increased—Fluorouracil—urinary bladder cancer	5.4e-05	0.000996	CcSEcCtD
Trabectedin—Paraesthesia—Etoposide—urinary bladder cancer	5.33e-05	0.000983	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—urinary bladder cancer	5.29e-05	0.000976	CcSEcCtD
Trabectedin—Dyspnoea—Etoposide—urinary bladder cancer	5.29e-05	0.000976	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	5.27e-05	0.000972	CcSEcCtD
Trabectedin—Vomiting—Thiotepa—urinary bladder cancer	5.25e-05	0.000969	CcSEcCtD
Trabectedin—Infestation—Epirubicin—urinary bladder cancer	5.22e-05	0.000962	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—urinary bladder cancer	5.22e-05	0.000962	CcSEcCtD
Trabectedin—Rash—Thiotepa—urinary bladder cancer	5.21e-05	0.000961	CcSEcCtD
Trabectedin—Dermatitis—Thiotepa—urinary bladder cancer	5.2e-05	0.00096	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—urinary bladder cancer	5.2e-05	0.000959	CcSEcCtD
Trabectedin—Headache—Thiotepa—urinary bladder cancer	5.17e-05	0.000955	CcSEcCtD
Trabectedin—Decreased appetite—Etoposide—urinary bladder cancer	5.16e-05	0.000952	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—urinary bladder cancer	5.14e-05	0.000948	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	5.12e-05	0.000945	CcSEcCtD
Trabectedin—Body temperature increased—Cisplatin—urinary bladder cancer	5.12e-05	0.000945	CcSEcCtD
Trabectedin—Fatigue—Etoposide—urinary bladder cancer	5.12e-05	0.000944	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—urinary bladder cancer	5.08e-05	0.000938	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—urinary bladder cancer	5.08e-05	0.000938	CcSEcCtD
Trabectedin—Constipation—Etoposide—urinary bladder cancer	5.07e-05	0.000936	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—urinary bladder cancer	5.06e-05	0.000934	CcSEcCtD
Trabectedin—Hypersensitivity—Fluorouracil—urinary bladder cancer	5.03e-05	0.000929	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—urinary bladder cancer	5.03e-05	0.000928	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—urinary bladder cancer	5e-05	0.000923	CcSEcCtD
Trabectedin—Asthenia—Gemcitabine—urinary bladder cancer	4.99e-05	0.00092	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	4.93e-05	0.00091	CcSEcCtD
Trabectedin—Nausea—Thiotepa—urinary bladder cancer	4.91e-05	0.000905	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—urinary bladder cancer	4.9e-05	0.000903	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—urinary bladder cancer	4.87e-05	0.000898	CcSEcCtD
Trabectedin—Gastrointestinal pain—Etoposide—urinary bladder cancer	4.85e-05	0.000895	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—urinary bladder cancer	4.83e-05	0.00089	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—urinary bladder cancer	4.83e-05	0.00089	CcSEcCtD
Trabectedin—Hypersensitivity—Cisplatin—urinary bladder cancer	4.77e-05	0.00088	CcSEcCtD
Trabectedin—Diarrhoea—Gemcitabine—urinary bladder cancer	4.75e-05	0.000877	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—urinary bladder cancer	4.71e-05	0.000868	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—urinary bladder cancer	4.7e-05	0.000868	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—urinary bladder cancer	4.7e-05	0.000868	CcSEcCtD
Trabectedin—Abdominal pain—Etoposide—urinary bladder cancer	4.69e-05	0.000865	CcSEcCtD
Trabectedin—Body temperature increased—Etoposide—urinary bladder cancer	4.69e-05	0.000865	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—urinary bladder cancer	4.68e-05	0.000864	CcSEcCtD
Trabectedin—Diarrhoea—Fluorouracil—urinary bladder cancer	4.67e-05	0.000862	CcSEcCtD
Trabectedin—Asthenia—Cisplatin—urinary bladder cancer	4.65e-05	0.000857	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—urinary bladder cancer	4.61e-05	0.000851	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—urinary bladder cancer	4.6e-05	0.000849	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	4.56e-05	0.000842	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—urinary bladder cancer	4.54e-05	0.000837	CcSEcCtD
Trabectedin—Dizziness—Fluorouracil—urinary bladder cancer	4.52e-05	0.000834	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—urinary bladder cancer	4.51e-05	0.000832	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—urinary bladder cancer	4.5e-05	0.000831	CcSEcCtD
Trabectedin—Diarrhoea—Cisplatin—urinary bladder cancer	4.43e-05	0.000818	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—urinary bladder cancer	4.42e-05	0.000816	CcSEcCtD
Trabectedin—Vomiting—Gemcitabine—urinary bladder cancer	4.42e-05	0.000815	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—urinary bladder cancer	4.38e-05	0.000809	CcSEcCtD
Trabectedin—Rash—Gemcitabine—urinary bladder cancer	4.38e-05	0.000808	CcSEcCtD
Trabectedin—Dermatitis—Gemcitabine—urinary bladder cancer	4.38e-05	0.000808	CcSEcCtD
Trabectedin—Hypersensitivity—Etoposide—urinary bladder cancer	4.37e-05	0.000807	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—urinary bladder cancer	4.35e-05	0.000803	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—urinary bladder cancer	4.35e-05	0.000803	CcSEcCtD
Trabectedin—Headache—Gemcitabine—urinary bladder cancer	4.35e-05	0.000803	CcSEcCtD
Trabectedin—Flushing—Epirubicin—urinary bladder cancer	4.34e-05	0.000802	CcSEcCtD
Trabectedin—Vomiting—Fluorouracil—urinary bladder cancer	4.34e-05	0.000801	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—urinary bladder cancer	4.33e-05	0.000799	CcSEcCtD
Trabectedin—Rash—Fluorouracil—urinary bladder cancer	4.31e-05	0.000795	CcSEcCtD
Trabectedin—Dermatitis—Fluorouracil—urinary bladder cancer	4.3e-05	0.000794	CcSEcCtD
Trabectedin—Headache—Fluorouracil—urinary bladder cancer	4.28e-05	0.00079	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—urinary bladder cancer	4.27e-05	0.000787	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—urinary bladder cancer	4.26e-05	0.000787	CcSEcCtD
Trabectedin—Asthenia—Etoposide—urinary bladder cancer	4.26e-05	0.000785	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	4.26e-05	0.000785	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—urinary bladder cancer	4.25e-05	0.000784	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—urinary bladder cancer	4.22e-05	0.000778	CcSEcCtD
Trabectedin—Back pain—Methotrexate—urinary bladder cancer	4.21e-05	0.000777	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—urinary bladder cancer	4.14e-05	0.000763	CcSEcCtD
Trabectedin—Nausea—Gemcitabine—urinary bladder cancer	4.13e-05	0.000762	CcSEcCtD
Trabectedin—Vomiting—Cisplatin—urinary bladder cancer	4.12e-05	0.00076	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—urinary bladder cancer	4.1e-05	0.000757	CcSEcCtD
Trabectedin—Rash—Cisplatin—urinary bladder cancer	4.08e-05	0.000753	CcSEcCtD
Trabectedin—Dermatitis—Cisplatin—urinary bladder cancer	4.08e-05	0.000753	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—urinary bladder cancer	4.08e-05	0.000752	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—urinary bladder cancer	4.06e-05	0.000749	CcSEcCtD
Trabectedin—Nausea—Fluorouracil—urinary bladder cancer	4.06e-05	0.000749	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—urinary bladder cancer	4.03e-05	0.000743	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—urinary bladder cancer	4.02e-05	0.000742	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—urinary bladder cancer	3.99e-05	0.000736	CcSEcCtD
Trabectedin—Back pain—Epirubicin—urinary bladder cancer	3.94e-05	0.000727	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—urinary bladder cancer	3.93e-05	0.000725	CcSEcCtD
Trabectedin—Dizziness—Etoposide—urinary bladder cancer	3.92e-05	0.000724	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	3.9e-05	0.00072	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—urinary bladder cancer	3.9e-05	0.000719	CcSEcCtD
Trabectedin—Nausea—Cisplatin—urinary bladder cancer	3.85e-05	0.00071	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—urinary bladder cancer	3.83e-05	0.000706	CcSEcCtD
Trabectedin—Cough—Methotrexate—urinary bladder cancer	3.8e-05	0.000701	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—urinary bladder cancer	3.8e-05	0.0007	CcSEcCtD
Trabectedin—Vomiting—Etoposide—urinary bladder cancer	3.77e-05	0.000696	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—urinary bladder cancer	3.77e-05	0.000696	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—urinary bladder cancer	3.77e-05	0.000695	CcSEcCtD
Trabectedin—Rash—Etoposide—urinary bladder cancer	3.74e-05	0.00069	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—urinary bladder cancer	3.74e-05	0.00069	CcSEcCtD
Trabectedin—Headache—Etoposide—urinary bladder cancer	3.72e-05	0.000686	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—urinary bladder cancer	3.71e-05	0.000684	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—urinary bladder cancer	3.71e-05	0.000684	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—urinary bladder cancer	3.69e-05	0.000681	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.68e-05	0.000679	CcSEcCtD
Trabectedin—Syncope—Epirubicin—urinary bladder cancer	3.65e-05	0.000674	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—urinary bladder cancer	3.65e-05	0.000673	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—urinary bladder cancer	3.65e-05	0.000673	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—urinary bladder cancer	3.58e-05	0.000661	CcSEcCtD
Trabectedin—Cough—Epirubicin—urinary bladder cancer	3.56e-05	0.000656	CcSEcCtD
Trabectedin—Infection—Methotrexate—urinary bladder cancer	3.53e-05	0.000651	CcSEcCtD
Trabectedin—Nausea—Etoposide—urinary bladder cancer	3.52e-05	0.00065	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—urinary bladder cancer	3.49e-05	0.000643	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—urinary bladder cancer	3.49e-05	0.000643	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.48e-05	0.000642	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—urinary bladder cancer	3.47e-05	0.00064	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—urinary bladder cancer	3.47e-05	0.00064	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—urinary bladder cancer	3.45e-05	0.000637	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.45e-05	0.000636	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—urinary bladder cancer	3.39e-05	0.000625	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—urinary bladder cancer	3.38e-05	0.000624	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—urinary bladder cancer	3.38e-05	0.000623	CcSEcCtD
Trabectedin—Oedema—Epirubicin—urinary bladder cancer	3.33e-05	0.000614	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—urinary bladder cancer	3.32e-05	0.000613	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.31e-05	0.000611	CcSEcCtD
Trabectedin—Infection—Epirubicin—urinary bladder cancer	3.3e-05	0.00061	CcSEcCtD
Trabectedin—Cough—Doxorubicin—urinary bladder cancer	3.29e-05	0.000607	CcSEcCtD
Trabectedin—Shock—Epirubicin—urinary bladder cancer	3.27e-05	0.000604	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—urinary bladder cancer	3.26e-05	0.000602	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.26e-05	0.000601	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.24e-05	0.000597	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—urinary bladder cancer	3.23e-05	0.000596	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—urinary bladder cancer	3.21e-05	0.000593	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—urinary bladder cancer	3.21e-05	0.000592	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—urinary bladder cancer	3.21e-05	0.000592	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—urinary bladder cancer	3.19e-05	0.000589	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.19e-05	0.000588	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—urinary bladder cancer	3.17e-05	0.000585	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—urinary bladder cancer	3.17e-05	0.000585	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—urinary bladder cancer	3.13e-05	0.000577	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—urinary bladder cancer	3.11e-05	0.000573	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—urinary bladder cancer	3.09e-05	0.00057	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—urinary bladder cancer	3.08e-05	0.000568	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.07e-05	0.000566	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—urinary bladder cancer	3.06e-05	0.000565	CcSEcCtD
Trabectedin—Infection—Doxorubicin—urinary bladder cancer	3.06e-05	0.000564	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.03e-05	0.000559	CcSEcCtD
Trabectedin—Shock—Doxorubicin—urinary bladder cancer	3.03e-05	0.000559	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.02e-05	0.000557	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.01e-05	0.000556	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—urinary bladder cancer	3.01e-05	0.000555	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—urinary bladder cancer	2.99e-05	0.000552	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—urinary bladder cancer	2.99e-05	0.000551	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—urinary bladder cancer	2.97e-05	0.000547	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—urinary bladder cancer	2.93e-05	0.000541	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—urinary bladder cancer	2.93e-05	0.00054	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.91e-05	0.000536	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—urinary bladder cancer	2.89e-05	0.000533	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—urinary bladder cancer	2.88e-05	0.000531	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.87e-05	0.00053	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—urinary bladder cancer	2.87e-05	0.000529	CcSEcCtD
Trabectedin—Constipation—Epirubicin—urinary bladder cancer	2.84e-05	0.000525	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—urinary bladder cancer	2.81e-05	0.000518	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—urinary bladder cancer	2.81e-05	0.000518	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.8e-05	0.000517	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—urinary bladder cancer	2.78e-05	0.000514	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—urinary bladder cancer	2.76e-05	0.00051	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—urinary bladder cancer	2.74e-05	0.000506	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.72e-05	0.000502	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—urinary bladder cancer	2.71e-05	0.0005	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—urinary bladder cancer	2.68e-05	0.000494	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.66e-05	0.00049	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—urinary bladder cancer	2.65e-05	0.00049	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—urinary bladder cancer	2.63e-05	0.000486	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—urinary bladder cancer	2.63e-05	0.000485	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—urinary bladder cancer	2.63e-05	0.000485	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—urinary bladder cancer	2.62e-05	0.000483	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—urinary bladder cancer	2.55e-05	0.00047	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.52e-05	0.000464	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—urinary bladder cancer	2.45e-05	0.000452	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—urinary bladder cancer	2.43e-05	0.000449	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.43e-05	0.000449	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—urinary bladder cancer	2.43e-05	0.000449	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—urinary bladder cancer	2.39e-05	0.00044	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—urinary bladder cancer	2.35e-05	0.000434	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—urinary bladder cancer	2.28e-05	0.00042	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.27e-05	0.000418	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—urinary bladder cancer	2.26e-05	0.000417	CcSEcCtD
Trabectedin—Rash—Methotrexate—urinary bladder cancer	2.24e-05	0.000413	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—urinary bladder cancer	2.24e-05	0.000413	CcSEcCtD
Trabectedin—Headache—Methotrexate—urinary bladder cancer	2.23e-05	0.000411	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—urinary bladder cancer	2.21e-05	0.000407	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—urinary bladder cancer	2.2e-05	0.000406	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—urinary bladder cancer	2.11e-05	0.00039	CcSEcCtD
Trabectedin—Nausea—Methotrexate—urinary bladder cancer	2.11e-05	0.00039	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—urinary bladder cancer	2.11e-05	0.000389	CcSEcCtD
Trabectedin—Rash—Epirubicin—urinary bladder cancer	2.1e-05	0.000387	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—urinary bladder cancer	2.1e-05	0.000387	CcSEcCtD
Trabectedin—Headache—Epirubicin—urinary bladder cancer	2.08e-05	0.000384	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—urinary bladder cancer	2.04e-05	0.000375	CcSEcCtD
Trabectedin—Nausea—Epirubicin—urinary bladder cancer	1.98e-05	0.000365	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—urinary bladder cancer	1.96e-05	0.000361	CcSEcCtD
Trabectedin—Rash—Doxorubicin—urinary bladder cancer	1.94e-05	0.000358	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—urinary bladder cancer	1.94e-05	0.000358	CcSEcCtD
Trabectedin—Headache—Doxorubicin—urinary bladder cancer	1.93e-05	0.000356	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—urinary bladder cancer	1.83e-05	0.000337	CcSEcCtD
Trabectedin—PTGS1—Metabolism—RRM2—urinary bladder cancer	9.31e-06	0.000306	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—urinary bladder cancer	9.29e-06	0.000305	CbGpPWpGaD
Trabectedin—SRC—Disease—RBX1—urinary bladder cancer	9.28e-06	0.000305	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—urinary bladder cancer	9.2e-06	0.000303	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	9.14e-06	0.0003	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PPARG—urinary bladder cancer	9.13e-06	0.0003	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—urinary bladder cancer	9.12e-06	0.0003	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—FGFR3—urinary bladder cancer	9.1e-06	0.000299	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—urinary bladder cancer	9.08e-06	0.000299	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TYMP—urinary bladder cancer	8.91e-06	0.000293	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP9—urinary bladder cancer	8.82e-06	0.00029	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.82e-06	0.00029	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—urinary bladder cancer	8.78e-06	0.000288	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CREBBP—urinary bladder cancer	8.77e-06	0.000288	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—FGFR3—urinary bladder cancer	8.73e-06	0.000287	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—HPGDS—urinary bladder cancer	8.62e-06	0.000283	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ENO2—urinary bladder cancer	8.62e-06	0.000283	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—CREBBP—urinary bladder cancer	8.6e-06	0.000283	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	8.6e-06	0.000283	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8.59e-06	0.000282	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.57e-06	0.000282	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	8.52e-06	0.00028	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IGF1—urinary bladder cancer	8.49e-06	0.000279	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTT1—urinary bladder cancer	8.36e-06	0.000275	CbGpPWpGaD
Trabectedin—SRC—Disease—JAG1—urinary bladder cancer	8.31e-06	0.000273	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.23e-06	0.000271	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	8.23e-06	0.00027	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	8.11e-06	0.000267	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NAT2—urinary bladder cancer	8.06e-06	0.000265	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	8.04e-06	0.000264	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—RHOA—urinary bladder cancer	7.93e-06	0.000261	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.91e-06	0.00026	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—urinary bladder cancer	7.88e-06	0.000259	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	7.84e-06	0.000258	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—RHOA—urinary bladder cancer	7.78e-06	0.000256	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CREBBP—urinary bladder cancer	7.74e-06	0.000254	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNA2—urinary bladder cancer	7.7e-06	0.000253	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KRAS—urinary bladder cancer	7.44e-06	0.000245	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDH1—urinary bladder cancer	7.38e-06	0.000243	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ERBB2—urinary bladder cancer	7.34e-06	0.000241	CbGpPWpGaD
Trabectedin—SRC—Immune System—S100B—urinary bladder cancer	7.28e-06	0.000239	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.2e-06	0.000237	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—urinary bladder cancer	7.13e-06	0.000234	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—RRM2—urinary bladder cancer	6.95e-06	0.000229	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NQO1—urinary bladder cancer	6.95e-06	0.000228	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.89e-06	0.000227	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.87e-06	0.000226	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.82e-06	0.000224	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.82e-06	0.000224	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.74e-06	0.000222	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—urinary bladder cancer	6.74e-06	0.000221	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.6e-06	0.000217	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IL2—urinary bladder cancer	6.53e-06	0.000215	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RBX1—urinary bladder cancer	6.5e-06	0.000214	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB2—urinary bladder cancer	6.48e-06	0.000213	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ENO2—urinary bladder cancer	6.44e-06	0.000212	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	6.44e-06	0.000212	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—urinary bladder cancer	6.33e-06	0.000208	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.32e-06	0.000208	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—urinary bladder cancer	6.3e-06	0.000207	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.29e-06	0.000207	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	6.27e-06	0.000206	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	6.25e-06	0.000205	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.24e-06	0.000205	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB2—urinary bladder cancer	6.23e-06	0.000205	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	6.22e-06	0.000204	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSC1—urinary bladder cancer	6.11e-06	0.000201	CbGpPWpGaD
Trabectedin—SRC—Disease—NCOR1—urinary bladder cancer	6.05e-06	0.000199	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.02e-06	0.000198	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EP300—urinary bladder cancer	5.97e-06	0.000196	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.88e-06	0.000193	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—EP300—urinary bladder cancer	5.86e-06	0.000193	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JAG1—urinary bladder cancer	5.82e-06	0.000191	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTP1—urinary bladder cancer	5.79e-06	0.00019	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—urinary bladder cancer	5.73e-06	0.000188	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.72e-06	0.000188	CbGpPWpGaD
Trabectedin—SRC—Disease—ERCC2—urinary bladder cancer	5.69e-06	0.000187	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.67e-06	0.000186	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.62e-06	0.000185	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.61e-06	0.000184	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1A—urinary bladder cancer	5.54e-06	0.000182	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTEN—urinary bladder cancer	5.53e-06	0.000182	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TYMS—urinary bladder cancer	5.39e-06	0.000177	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5.37e-06	0.000176	CbGpPWpGaD
Trabectedin—SRC—Disease—MTHFR—urinary bladder cancer	5.34e-06	0.000176	CbGpPWpGaD
Trabectedin—SRC—Disease—TERT—urinary bladder cancer	5.33e-06	0.000175	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTM1—urinary bladder cancer	5.32e-06	0.000175	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NCOR1—urinary bladder cancer	5.32e-06	0.000175	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1A—urinary bladder cancer	5.32e-06	0.000175	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTEN—urinary bladder cancer	5.31e-06	0.000175	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.31e-06	0.000174	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGFR3—urinary bladder cancer	5.3e-06	0.000174	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EP300—urinary bladder cancer	5.27e-06	0.000173	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NQO1—urinary bladder cancer	5.19e-06	0.000171	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.17e-06	0.00017	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GPX1—urinary bladder cancer	5.1e-06	0.000168	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—urinary bladder cancer	5.09e-06	0.000167	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ERCC2—urinary bladder cancer	5.01e-06	0.000165	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.97e-06	0.000163	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.97e-06	0.000163	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.94e-06	0.000162	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.93e-06	0.000162	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.89e-06	0.000161	CbGpPWpGaD
Trabectedin—SRC—Disease—FGFR3—urinary bladder cancer	4.89e-06	0.000161	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—urinary bladder cancer	4.85e-06	0.000159	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.82e-06	0.000158	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—urinary bladder cancer	4.81e-06	0.000158	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.75e-06	0.000156	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—urinary bladder cancer	4.72e-06	0.000155	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—S100B—urinary bladder cancer	4.71e-06	0.000155	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—MTHFR—urinary bladder cancer	4.71e-06	0.000155	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.57e-06	0.00015	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.57e-06	0.00015	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.53e-06	0.000149	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.53e-06	0.000149	CbGpPWpGaD
Trabectedin—SRC—Immune System—CREBBP—urinary bladder cancer	4.51e-06	0.000148	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.5e-06	0.000148	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—urinary bladder cancer	4.49e-06	0.000148	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—urinary bladder cancer	4.48e-06	0.000147	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.43e-06	0.000146	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.39e-06	0.000144	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	4.33e-06	0.000142	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.33e-06	0.000142	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—urinary bladder cancer	4.32e-06	0.000142	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—urinary bladder cancer	4.25e-06	0.00014	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NCOR1—urinary bladder cancer	4.23e-06	0.000139	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—urinary bladder cancer	4.19e-06	0.000138	CbGpPWpGaD
Trabectedin—SRC—Disease—CREBBP—urinary bladder cancer	4.16e-06	0.000137	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.13e-06	0.000136	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—urinary bladder cancer	4.09e-06	0.000134	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—urinary bladder cancer	4.08e-06	0.000134	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TYMS—urinary bladder cancer	4.03e-06	0.000132	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—urinary bladder cancer	4.01e-06	0.000132	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	4.01e-06	0.000132	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.98e-06	0.000131	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.98e-06	0.000131	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.89e-06	0.000128	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPARG—urinary bladder cancer	3.82e-06	0.000125	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.81e-06	0.000125	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—urinary bladder cancer	3.78e-06	0.000124	CbGpPWpGaD
Trabectedin—SRC—Disease—RHOA—urinary bladder cancer	3.77e-06	0.000124	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.74e-06	0.000123	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.74e-06	0.000123	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—urinary bladder cancer	3.73e-06	0.000123	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.68e-06	0.000121	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CREBBP—urinary bladder cancer	3.67e-06	0.00012	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.65e-06	0.00012	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—urinary bladder cancer	3.61e-06	0.000119	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.54e-06	0.000116	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.52e-06	0.000116	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—urinary bladder cancer	3.49e-06	0.000115	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—urinary bladder cancer	3.47e-06	0.000114	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGFR3—urinary bladder cancer	3.42e-06	0.000113	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—urinary bladder cancer	3.42e-06	0.000113	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—urinary bladder cancer	3.41e-06	0.000112	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.39e-06	0.000111	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.34e-06	0.00011	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ESR1—urinary bladder cancer	3.33e-06	0.000109	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.23e-06	0.000106	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—urinary bladder cancer	3.23e-06	0.000106	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.23e-06	0.000106	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—urinary bladder cancer	3.22e-06	0.000106	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.11e-06	0.000102	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.09e-06	0.000102	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.07e-06	0.000101	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—urinary bladder cancer	3.07e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.07e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.07e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	3.05e-06	0.0001	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—urinary bladder cancer	3e-06	9.87e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.99e-06	9.82e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.99e-06	9.82e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—urinary bladder cancer	2.98e-06	9.8e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—urinary bladder cancer	2.97e-06	9.77e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.95e-06	9.69e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.94e-06	9.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CREBBP—urinary bladder cancer	2.92e-06	9.58e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.9e-06	9.53e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.89e-06	9.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1—urinary bladder cancer	2.88e-06	9.46e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.86e-06	9.39e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.85e-06	9.37e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—urinary bladder cancer	2.84e-06	9.32e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.83e-06	9.31e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.82e-06	9.28e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.82e-06	9.28e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.8e-06	9.2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.8e-06	9.2e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.74e-06	9e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.71e-06	8.92e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.7e-06	8.89e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.68e-06	8.81e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.65e-06	8.73e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RHOA—urinary bladder cancer	2.64e-06	8.67e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.63e-06	8.65e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—urinary bladder cancer	2.62e-06	8.61e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—urinary bladder cancer	2.62e-06	8.6e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—urinary bladder cancer	2.5e-06	8.21e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.5e-06	8.2e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.47e-06	8.13e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—urinary bladder cancer	2.47e-06	8.13e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—urinary bladder cancer	2.47e-06	8.12e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—urinary bladder cancer	2.44e-06	8.03e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—urinary bladder cancer	2.42e-06	7.94e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.41e-06	7.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—urinary bladder cancer	2.32e-06	7.61e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—urinary bladder cancer	2.28e-06	7.5e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.24e-06	7.37e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—urinary bladder cancer	2.21e-06	7.27e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.2e-06	7.23e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—urinary bladder cancer	2.16e-06	7.09e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.11e-06	6.95e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—urinary bladder cancer	2.1e-06	6.91e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—urinary bladder cancer	2.09e-06	6.88e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—urinary bladder cancer	2.09e-06	6.86e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—urinary bladder cancer	2.08e-06	6.84e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.02e-06	6.65e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.01e-06	6.6e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.01e-06	6.59e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—urinary bladder cancer	1.99e-06	6.53e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.96e-06	6.43e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.94e-06	6.39e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—urinary bladder cancer	1.94e-06	6.38e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.93e-06	6.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.87e-06	6.14e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.87e-06	6.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.85e-06	6.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.85e-06	6.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.77e-06	5.81e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.74e-06	5.71e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.73e-06	5.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—urinary bladder cancer	1.73e-06	5.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—urinary bladder cancer	1.69e-06	5.56e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.63e-06	5.36e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—urinary bladder cancer	1.6e-06	5.26e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.59e-06	5.23e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.58e-06	5.19e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.51e-06	4.96e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.44e-06	4.73e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—urinary bladder cancer	1.42e-06	4.67e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.39e-06	4.56e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.38e-06	4.52e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—urinary bladder cancer	1.36e-06	4.47e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.32e-06	4.35e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.32e-06	4.35e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.31e-06	4.31e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.27e-06	4.18e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.04e-06	3.42e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.08e-07	2.98e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.66e-07	2.85e-05	CbGpPWpGaD
